# Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD

> **NCT02097992** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Miami** · enrollment: 11 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Roflumilast Placebo
- **DRUG:** Roflumilast

## Key facts

- **NCT ID:** NCT02097992
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2017-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02097992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02097992, "Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02097992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*